ORAL Αvβ6/αvβ1 INTEGRIN INHIBITION IN PRIMARY SCLEROSING CHOLANGITIS: 12-WEEK INTERIM SAFETY AND EFFICACY ANALYSIS OF INTEGRIS-PSC, A PHASE 2a TRIAL OF BEXOTEGRAST
HEPATOLOGY(2024)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined